Clinical trials: COVID 19 Associated Coagulopathy
COVID
RAS and Coagulopathy in COVID19
To determine whether the coagulopathy associated with COVID-19 infection is driven by overactivation of the renin angiotensin system (RAS)
- Trial name
- NCT04419610
- Testing
- TRV027, sodium chloride 0.9%
- Where
- United Kingdom
- Volunteers
- 28 people
- Sponsor
- Imperial College London
COVID 19 Associated Coagulopathy
Covid-19 Associated Coagulopathy
This prospective, randomized, open-label, multi-center interventional study is designed to compare the safety and efficacy of two LMWH dosing protocols in patients admitted to the University of Iowa Hospitals with COVID-19 who…
- Trial name
- NCT04360824
- Testing
- Intermediate dose thromboprophylaxis, Standard of Care thromboprophylaxis
- Where
- 2 sites in United States
- Volunteers
- 176 people
- Sponsor
- University of Iowa